These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 25527046)
1. High expression of CXCR3 is an independent prognostic factor in glioblastoma patients that promotes an invasive phenotype. Pu Y; Li S; Zhang C; Bao Z; Yang Z; Sun L J Neurooncol; 2015 Mar; 122(1):43-51. PubMed ID: 25527046 [TBL] [Abstract][Full Text] [Related]
2. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma. Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of chemokine receptor CXCR3 and its ligand CXCL10 in low-grade astrocytomas and glioblastoma multiforme: A tissue microarray-based comparison. Sharma I; Siraj F; Sharma KC; Singh A J Cancer Res Ther; 2016; 12(2):793-7. PubMed ID: 27461653 [TBL] [Abstract][Full Text] [Related]
4. The regulation of cysteine cathepsins and cystatins in human gliomas. Gole B; Huszthy PC; Popović M; Jeruc J; Ardebili YS; Bjerkvig R; Lah TT Int J Cancer; 2012 Oct; 131(8):1779-89. PubMed ID: 22287159 [TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma. Rutkowski MJ; Sughrue ME; Kane AJ; Kim JM; Bloch O; Parsa AT J Neurooncol; 2011 Nov; 105(2):165-71. PubMed ID: 21503828 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1. Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733 [TBL] [Abstract][Full Text] [Related]
7. Microenvironment involved in FPR1 expression by human glioblastomas. Boer JC; van Marion DM; Joseph JV; Kliphuis NM; Timmer-Bosscha H; van Strijp JA; de Vries EG; den Dunnen WF; Kruyt FA; Walenkamp AM J Neurooncol; 2015 May; 123(1):53-63. PubMed ID: 25894595 [TBL] [Abstract][Full Text] [Related]
8. Control of glioma cell migration and invasiveness by GDF-15. Codó P; Weller M; Kaulich K; Schraivogel D; Silginer M; Reifenberger G; Meister G; Roth P Oncotarget; 2016 Feb; 7(7):7732-46. PubMed ID: 26741507 [TBL] [Abstract][Full Text] [Related]
9. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma. Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287 [TBL] [Abstract][Full Text] [Related]
11. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness. Lemke D; Pfenning PN; Sahm F; Klein AC; Kempf T; Warnken U; Schnölzer M; Tudoran R; Weller M; Platten M; Wick W Clin Cancer Res; 2012 Jan; 18(1):105-17. PubMed ID: 22080438 [TBL] [Abstract][Full Text] [Related]
12. Effect of Concomitant Radiochemotherapy on Invasion Potential of Glioblastoma. Hutóczki G; Bognár L; Tóth J; Scholtz B; Zahuczky G; Hanzély Z; Csősz É; Reményi-Puskár J; Kalló G; Hortobágyi T; Klekner A Pathol Oncol Res; 2016 Jan; 22(1):155-60. PubMed ID: 26450124 [TBL] [Abstract][Full Text] [Related]
13. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells. Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9. Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279 [TBL] [Abstract][Full Text] [Related]
15. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution. Metellus P; Nanni-Metellus I; Delfino C; Colin C; Tchogandjian A; Coulibaly B; Fina F; Loundou A; Barrie M; Chinot O; Ouafik L; Figarella-Branger D Ann Surg Oncol; 2011 Oct; 18(10):2937-45. PubMed ID: 21479688 [TBL] [Abstract][Full Text] [Related]
17. TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients. Wang C; Cao S; Yan Y; Ying Q; Jiang T; Xu K; Wu A BMC Cancer; 2010 Aug; 10():415. PubMed ID: 20696081 [TBL] [Abstract][Full Text] [Related]
18. High expression of PCBP2 is associated with progression and poor prognosis in patients with glioblastoma. Luo K; Zhuang K Biomed Pharmacother; 2017 Oct; 94():659-665. PubMed ID: 28787701 [TBL] [Abstract][Full Text] [Related]
19. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma. Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080 [TBL] [Abstract][Full Text] [Related]
20. An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9. Ding Q; Xia Y; Ding S; Lu P; Sun L; Liu M Oncotarget; 2016 Mar; 7(12):14405-14. PubMed ID: 26883105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]